ClinicalTrials.govpublic full text
BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma.
lymphoblastic lymphoma, adult, lymphoblastic leukemia, acute t-cell, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 913922
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.